Opinicus Capital’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
ECSS
Opinicus Capital's MRK Position: Q2 2026 in Review
Opinicus Capital increased its Merck (MRK) stake by 11% in Q2 2026, buying an estimated $134K and bringing the position to 11,664 shares worth $1.5M. The position accounts for 0.8% of the portfolio, ranked #37.
Opinicus Capital first reported a position in MRK in Q4 2023 and has held it in 11 quarters since. 1,752 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Opinicus Capital held 11,664 shares of Merck worth $1.5M as of Q2 2026.
- Opinicus Capital bought 1,141 Merck shares in Q2 2026, an estimated $134K.
- Merck made up 0.8% of Opinicus Capital's portfolio in Q2 2026, its #37 holding.
- Opinicus Capital first reported a position in Merck in Q4 2023 and has held it in 11 quarters since.
- 1,752 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Opinicus Capital's 13F filing for Q2 2026, filed 27 Jul 2026.